586 related articles for article (PubMed ID: 33081223)
1. A Review of Molecular Imaging of Glutamate Receptors.
Kim JH; Marton J; Ametamey SM; Cumming P
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081223
[TBL] [Abstract][Full Text] [Related]
2. PET and SPECT tracers for glutamate receptors.
Majo VJ; Prabhakaran J; Mann JJ; Kumar JS
Drug Discov Today; 2013 Feb; 18(3-4):173-84. PubMed ID: 23092894
[TBL] [Abstract][Full Text] [Related]
3. Development of PET and SPECT probes for glutamate receptors.
Fuchigami T; Nakayama M; Yoshida S
ScientificWorldJournal; 2015; 2015():716514. PubMed ID: 25874256
[TBL] [Abstract][Full Text] [Related]
4. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
Kew JN; Kemp JA
Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
[TBL] [Abstract][Full Text] [Related]
5. Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
Stone JM
Curr Pharm Des; 2009; 15(22):2594-602. PubMed ID: 19689330
[TBL] [Abstract][Full Text] [Related]
6. [Role of excitatory amino acids in neuropathology].
Wikinski SI; Acosta GB
Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
[TBL] [Abstract][Full Text] [Related]
7. Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5.
Yu M
Curr Top Med Chem; 2007; 7(18):1800-5. PubMed ID: 17979788
[TBL] [Abstract][Full Text] [Related]
8. Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors.
Fu H; Chen Z; Josephson L; Li Z; Liang SH
J Med Chem; 2019 Jan; 62(2):403-419. PubMed ID: 30110164
[TBL] [Abstract][Full Text] [Related]
9. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
[TBL] [Abstract][Full Text] [Related]
10. PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development.
Sobrio F; Gilbert G; Perrio C; Barré L; Debruyne D
Mini Rev Med Chem; 2010 Aug; 10(9):870-86. PubMed ID: 20504276
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic targets for new alcohol medications.
Holmes A; Spanagel R; Krystal JH
Psychopharmacology (Berl); 2013 Oct; 229(3):539-54. PubMed ID: 23995381
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.
Sobrio F
J Labelled Comp Radiopharm; 2013; 56(3-4):180-6. PubMed ID: 24285324
[TBL] [Abstract][Full Text] [Related]
13. Imaging the glutamatergic system in vivo--relevance to schizophrenia.
Bressan RA; Pilowsky LS
Eur J Nucl Med; 2000 Nov; 27(11):1723-31. PubMed ID: 11105831
[TBL] [Abstract][Full Text] [Related]
14. The Role of Glutamate Receptors in Epilepsy.
Chen TS; Huang TH; Lai MC; Huang CW
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979762
[TBL] [Abstract][Full Text] [Related]
15. Selective metabotropic receptor agonists distinguish non-ionotropic glutamate binding sites.
Testa CM; Hollingsworth ZR; Shinozaki H; Penney JB; Young AB
Brain Res; 1997 Oct; 773(1-2):15-27. PubMed ID: 9409700
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical imaging in schizophrenia.
Urban N; Abi-Dargham A
Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
